Increasing research activities for treatment of PPD is expected to propel growth of the postpartum depression drug market during the forecast period. For instance, Sage Therapeutics is undergoing phase 3 clinical study for the drug —Brexanolone, which might be useful in the treatment of PPD. The study started in May 2018 and is estimated to […]
from LinkeWire http://bit.ly/2N6XTfK
from LinkeWire http://bit.ly/2N6XTfK
Comments
Post a Comment